The size of the Empty Capsules Market in the European region is estimated to be USD 477.77 million by 2026 from USD 350.35 million in 2021, growing at a CAGR of 6.4% from 2021 to 2026.
Gelatin is a protein produced by plants and animals that are used to make empty capsules. Prescription and over-the-counter medications, nutrient supplements, and herbal products all employ this dosage form.
The rising prevalence of non-communicable diseases such as cancer, diabetes, heart disease, and lung disorders has increased nutraceuticals. As most nutraceuticals are sold in capsule form, this is a good sign of market expansion. In addition, the empty capsules are useful for masking the taste of cardiovascular medications, which significantly favored the market in the European region. As a result, the post-pandemic rise of the empty capsule market is expected to accelerate. Furthermore, the expanding number of medications marketed as capsule formulations and the rising prevalence of disorders for which capsule-based formulations are principal treatments are driving demand for empty capsules in the pharmaceutical business.
However, factors such as ethical concerns, price variations in gelatin materials, and tight regulations in the pharmaceutical business are expected to negatively impact the European empty capsules market during the forecast period. Furthermore, the growth of the European empty capsule market is further expected to be hampered by a dearth of trained laboratory workers and the government’s strict rules and regulations requiring only high-quality medicines to be approved. Additionally, a lack of awareness about how to use these goods is slowing the growth of the empty capsules market.
This research report on the European empty capsules market has been segmented and sub-segmented into the following categories:
By Product:
By Therapeutic Application:
By End User:
By Country:
Geographically, the European market is the second-largest regional market for the global empty capsules market. The market’s demand for empty capsules is expanding as a result of their easy absorption rate. In addition, an ever-increasing patient pool is also a driving force in the market. Germany and the United Kingdom are at the top of the market, with increased backing from commercial and state institutions.
The largest product segment is gelatin capsules, whereas non-gelatin capsules are expected to grow at the fastest rate, with a high CAGR, due to a growing desire for vegetable origin capsules. For the empty capsules market, the pharmaceutical industry is the major end-user category. Empty capsules are in more demand due to the growing emphasis on superior pharmaceutical items and generics. Qualicaps Europe S.A.U expanded its presence in South Asia in February 2021. The company has capsule manufacturing professionals in EMEA and South Asia and two production sites in Europe. The high prevalence of cardiovascular illness in the United Kingdom pushes up demand for effective cardiovascular therapy medications, promoting the market’s growth.
KEY MARKET PLAYERS:
A few noteworthy companies operating in the European empty capsules market profiled in this report are Capsugel, ACG Worldwide, Suheung Co Ltd., Bright Pharmacaps Inc., Capscanada Corporation, Medi-Caps Ltd., Qualicaps, Roxlor, LLC, Snail Pharma Industry Co.Ltd, and Sunil Healthcare Limited.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 Gelatin Capsules
5.1.2 Non Gelatin Capsules
5.2 By Therapeutic Applcation
5.2.1 Antibiotic and Antibacterial Drugs
5.2.2 Vitamins and Dietary Supplements
5.2.3 Antacid and Antiflatulent Preparations
5.2.4 Antianemic Preparations
5.2.5 Anti-Inflammatory Drugs
5.2.6 Cardiovascular Therapy Drugs
5.2.7 Cough and Cold Preparations
5.2.8 Other therapeutic applications
5.3 By End User
5.3.1 Pharmaceutical Industry
5.3.2 Nutraceutical Industry
5.3.3 Cosmetics Industry
5.3.4 Research Laboratories
6. Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Capsugel
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Suheung Co Ltd.
8.3 Acg Worldwide
8.4 Bright Pharmacaps Inc.
8.5 Capscanada Corporation
8.6 Medi-Caps Ltd.
8.7 Qualicaps
8.8 Roxlor, LLC
8.9 Snail Pharma Industry Co., Ltd.
8.10 Sunil Healthcare Limited
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
